Newsroom
Image
In celebration of Brett Monia, Ph.D., recipient of the 2025 Oligonucleotide Therapeutics Society (OTS) Lifetime Achievement Award, colleagues and peers reflect on his extraordinary impact on science, leadership and patient care.
Innovation at Work
Hear Dr. Sam Tsimikas, SVP of Global Cardiovascular Development, share how Ionis is redefining cardiometabolic care.
Image
Defining Moments
Ionis CEO Brett Monia, Ph.D. shares the journey to becoming a fully integrated biotech, advancing RNA-targeted medicines and delivering greater impact for patients.
Image
Defining Moments
Championing an investigational medicine to make a meaningful difference in the lives of those living with HAE
Image
Sign up for investor news alerts
For the latest on Ionis investor news.